J. de Ruijter
- Sanfilippo disease (mucopolysaccharidosis type III): Early diagnosis and treatment
- Award date
- 18 September 2013
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
Mucopolysaccharidoses (MPS) are severe, inherited metabolic disorders caused by defective lysosomal degradation glycosaminoglycans (GAGs). The subsequent progressive accumulation of GAGs in cells and tissues in MPS patients results in extensive, severe and progressive disease, generally limiting quality of life and life expectancy. Sanfilippo disease (mucopolysaccharidosis type III, MPS III) is one of the 7 MPSs and is characterized by storage of the GAG heparan sulfate (HS), primarily leading to severe neurological symptoms, caused by rapid deterioration of brain functions. This thesis comprises several studies, all initiated with the purpose to obtain more insight in the pathophysiology of the disease and to improve treatment and care of Sanfilippo patients.
- Research conducted at: Universiteit van Amsterdam
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.